FNTB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.171800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.587200E-01
Normal-vs-Stage2
7.283400E-01
Normal-vs-Stage3
7.226400E-01
Normal-vs-Stage4
6.689200E-01
Stage1-vs-Stage2
2.167400E-01
Stage1-vs-Stage3
5.720600E-01
Stage1-vs-Stage4
5.596400E-01
Stage2-vs-Stage3
3.578000E-01
Stage2-vs-Stage4
7.487800E-01
Stage3-vs-Stage4
4.274600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.066800E-01
Normal-vs-AfricanAmerican
8.637400E-01
Normal-vs-Asian
9.797000E-01
Caucasian-vs-AfricanAmerican
4.566200E-01
Caucasian-vs-Asian
5.032400E-01
AfricanAmerican-vs-Asian
7.832200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.405200E-01
Normal-vs-Female
6.954200E-01
Male-vs-Female
9.807800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.990200E-01
Normal-vs-Age(41-60Yrs)
4.804200E-01
Normal-vs-Age(61-80Yrs)
9.033600E-01
Normal-vs-Age(81-100Yrs)
9.950400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.519780E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.012400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.956200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.252270E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.655800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.019200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.560800E-01
Normal-vs-Daily Drinker
8.037000E-01
Normal-vs-Weekly Drinker
7.955000E-01
Normal-vs-Occasional Drinker
5.042800E-01
Normal-vs-Social Drinker
4.918400E-01
Non Drinker-vs-Daily Drinker
3.396800E-01
Non Drinker-vs-Weekly Drinker
2.567800E-01
Non Drinker-vs-Occasional Drinker
4.136300E-02
Non Drinker-vs-Social Drinker
7.478000E-02
Daily Drinker-vs-Weekly Drinker
7.327600E-01
Daily Drinker-vs-Occasional Drinker
9.863400E-01
Daily Drinker-vs-Social Drinker
5.650200E-01
Weekly Drinker-vs-Occasional Drinker
5.426400E-01
Weekly Drinker-vs-Social Drinker
2.588800E-01
Occasional Drinker-vs-Social Drinker
4.029800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.060400E-01
Normal-vs-Grade 2
6.410600E-01
Normal-vs-Grade 3
6.152600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.727600E-01
Grade 1-vs-Grade 3
8.327400E-01
Grade 1-vs-Grade 4
5.060400E-01
Grade 2-vs-Grade 3
5.437400E-01
Grade 2-vs-Grade 4
6.410600E-01
Grade 3-vs-Grade 4
6.152600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.371200E-01
Normal-vs-NonDiabetic
6.717800E-01
Diabetic-vs-NonDiabetic
5.106400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.977800E-01
Normal-vs-NoPancreatitis
7.497600E-01
Pancreatitis-vs-NoPancreatitis
6.943200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.466600E-01
Normal-vs-N1
7.136600E-01
N0-vs-N1
8.658200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.809400E-01
Normal-vs-TP53-NonMutant
9.677000E-01
TP53-Mutant-vs-TP53-NonMutant
5.723200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
